{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:34:07Z","timestamp":1788194047342,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001862","name":"the Swedish Research Council","doi-asserted-by":"crossref","award":["2019-01408"],"award-info":[{"award-number":["2019-01408"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Region Stockholm","award":["20190379"],"award-info":[{"award-number":["20190379"]}]},{"name":"Region Stockholm","award":["RS2020-0731"],"award-info":[{"award-number":["RS2020-0731"]}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2021-00505"],"award-info":[{"award-number":["2021-00505"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["FS-2022:0010"],"award-info":[{"award-number":["FS-2022:0010"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s40263-024-01108-w","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T12:02:14Z","timestamp":1722513734000},"page":"827-838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Incident Benzodiazepine and Z-Drug Use and Subsequent Risk of Serious Infections"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6218-5950","authenticated-orcid":false,"given":"Xinchen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Isomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lichtenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Kuja-Halkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M","family":"D\u2019Onofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Brikell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanbo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya","family":"Jayaram-Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mataix-Cols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sidorchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"issue":"7","key":"1108_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamapsychiatry.2017.1273","volume":"74","author":"GA Bushnell","year":"2017","unstructured":"Bushnell GA, Sturmer T, Gaynes BN, Pate V, Miller M. Simultaneous antidepressant and benzodiazepine new use and subsequent long-term benzodiazepine use in adults with depression, United States, 2001\u20132014. JAMA Psychiat. 2017;74(7):747\u201355.","journal-title":"JAMA Psychiat"},{"issue":"5","key":"1108_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000524400","volume":"91","author":"SL Dubovsky","year":"2022","unstructured":"Dubovsky SL, Marshall D. Benzodiazepines remain important therapeutic options in psychiatric practice. Psychother Psychosom. 2022;91(5):307\u201334.","journal-title":"Psychother Psychosom"},{"key":"1108_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12626","author":"L Wing\u00e5rd","year":"2018","unstructured":"Wing\u00e5rd L, et al. Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder. Bipolar Disord. 2018. https:\/\/doi.org\/10.1111\/bdi.12626.","journal-title":"Bipolar Disord"},{"issue":"4","key":"1108_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Nix CA, Hollier J, Sagrera CE, Delacroix BM, Abubakar T, et al. Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int. 2021;13(4):594\u2013607.","journal-title":"Neurol Int"},{"key":"1108_CR5","doi-asserted-by":"publisher","DOI":"10.2165\/11533170-000000000-00000","author":"BE Smink","year":"2010","unstructured":"Smink BE, Egberts ACG, Lusthof KJ, Uges DRA, de Gier JJ. The relationship between benzodiazepine use and traffic accidents: a systematic literature review. CNS Drugs. 2010. https:\/\/doi.org\/10.2165\/11533170-000000000-00000.","journal-title":"CNS Drugs"},{"issue":"4","key":"1108_CR6","doi-asserted-by":"publisher","first-page":"372.e1","DOI":"10.1016\/j.jamda.2017.12.099","volume":"19","author":"LJ Seppala","year":"2018","unstructured":"Seppala LJ, van de Glind EMM, Daams JG, Ploegmakers KJ, de Vries M, Wermelink A, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc. 2018;19(4):372.e1-372.e8.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"1108_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/ageing\/afx167","volume":"47","author":"N Treves","year":"2018","unstructured":"Treves N, Perlman A, Kolenberg Geron L, Asaly A, Matok I. Z-drugs and risk for falls and fractures in older adults\u2014a systematic review and meta-analysis. Age Ageing. 2018;47(2):201\u20138.","journal-title":"Age Ageing"},{"key":"1108_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01821-5","author":"K Richardson","year":"2020","unstructured":"Richardson K, Loke YK, Fox C, Maidment I, Howard R, Steel N, et al. Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study. BMC Med. 2020. https:\/\/doi.org\/10.1186\/s12916-020-01821-5.","journal-title":"BMC Med"},{"key":"1108_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40263-018-0535-3","volume":"32","author":"R Penninkilampi","year":"2018","unstructured":"Penninkilampi R, Eslick GD. A systematic review and meta-analysis of the risk of dementia associated with benzodiazepine use, after controlling for protopathic bias. CNS Drugs. 2018;32:485\u201397. https:\/\/doi.org\/10.1007\/s40263-018-0535-3.","journal-title":"CNS Drugs"},{"issue":"1","key":"1108_CR10","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.2146\/ajhp160381","volume":"75","author":"JD Picton","year":"2018","unstructured":"Picton JD, Marino AB, Nealy KL. Benzodiazepine use and cognitive decline in the elderly. Am J Health Syst Pharm. 2018;75(1):e5\u201312.","journal-title":"Am J Health Syst Pharm"},{"key":"1108_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2015.04.001","volume":"282","author":"RD Sanders","year":"2015","unstructured":"Sanders RD, Grover V, Goulding J, Godlee A, Gurney S, Snelgrove R, et al. Immune cell expression of GABAA receptors and the effects of diazepam on influenza infection. J Neuroimmunol. 2015;282:97\u2013103.","journal-title":"J Neuroimmunol"},{"issue":"38","key":"1108_CR12","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1016\/j.vaccine.2010.07.032","volume":"28","author":"HP Huemer","year":"2010","unstructured":"Huemer HP, Lassnig C, Nowotny N, Irschick EU, Kitchen M, Pavlic M. Diazepam leads to enhanced severity of orthopoxvirus infection and immune suppression. Vaccine. 2010;28(38):6152\u20138.","journal-title":"Vaccine"},{"key":"1108_CR13","doi-asserted-by":"publisher","DOI":"10.3109\/08923970009026012","author":"M Domingues-Junior","year":"2000","unstructured":"Domingues-Junior M, Pinheiro SR, Guerra JL, Palermo-Neto J. Effects of treatment with amphetamine and diazepam on mycobacterium bovis-induced infection in hamsters. Immunopharmacol Immunotoxicol. 2000. https:\/\/doi.org\/10.3109\/08923970009026012.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"26","key":"1108_CR14","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/0024-3205(95)02199-0","volume":"57","author":"F Galdiero","year":"1995","unstructured":"Galdiero F, Bentivoglio C, Nuzzo I, Ianniello R, Capasso C, Mattera S, et al. Effects of benzodiazepines on immunodeficiency and resistance in mice. Life Sci. 1995;57(26):2413\u201323.","journal-title":"Life Sci"},{"issue":"4","key":"1108_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","volume":"17","author":"J Brandt","year":"2017","unstructured":"Brandt J, Leong C. Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R D. 2017;17(4):493\u2013507. https:\/\/doi.org\/10.1007\/s40268-017-0207-7.","journal-title":"Drugs R D"},{"key":"1108_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/gps.5048","author":"G Sun","year":"2019","unstructured":"Sun G, Zhang L, Zhang L, Wu Z, Hu D. Benzodiazepines or related drugs and risk of pneumonia: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2019. https:\/\/doi.org\/10.1002\/gps.5048.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"17","key":"1108_CR17","doi-asserted-by":"publisher","first-page":"9410","DOI":"10.3390\/ijerph18179410","volume":"18","author":"K-H Huang","year":"2021","unstructured":"Huang K-H, Tai C-J, Kuan Y-H, Chang Y-C, Tsai T-H, Lee C-Y. Pneumonia risk associated with the use of individual benzodiazepines and benzodiazepine related drugs among the elderly with Parkinson\u2019s disease. IJERPH. 2021;18(17):9410.","journal-title":"IJERPH"},{"key":"1108_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024180","author":"S-M Lin","year":"2019","unstructured":"Lin S-M, Yang S-H, Liang C-C, Huang H-K, Loh C-H. Association between benzodiazepine use and risks of chronic-onset poststroke pneumonia: a population-based cohort study. BMJ Open. 2019. https:\/\/doi.org\/10.1136\/bmjopen-2018-024180.","journal-title":"BMJ Open"},{"key":"1108_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000003134","author":"E Skicki","year":"2021","unstructured":"Skicki E, Morgan M, Brown C, Bradburn E, Rogers F. Benzodiazepines increase the likelihood of both infectious and thrombotic complications. J Trauma Acute Care Surg. 2021. https:\/\/doi.org\/10.1097\/TA.0000000000003134.","journal-title":"J Trauma Acute Care Surg"},{"key":"1108_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jpsychires.2014.03.017","volume":"54","author":"C-Y Huang","year":"2014","unstructured":"Huang C-Y, Chou FH-C, Huang Y-S, Yang C-J, Su Y-C, Juang S-Y, et al. The association between zolpidem and infection in patients with sleep disturbance. J Psychiatr Res. 2014;54:116\u201320.","journal-title":"J Psychiatr Res"},{"key":"1108_CR21","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27552","author":"FL Joya","year":"2009","unstructured":"Joya FL, Kripke DF, Loving RT, Dawson A, Kline LE. Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem. J Clin Sleep Med. 2009. https:\/\/doi.org\/10.5664\/jcsm.27552.","journal-title":"J Clin Sleep Med"},{"key":"1108_CR22","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.10094","author":"L Meng","year":"2022","unstructured":"Meng L, Huang J, He Q, Zhao Y, Zhao W, Tan J, et al. Hypnotics and infections: disproportionality analysis of the U.S. Food & Drug Administration adverse event reporting system database. J Clin Sleep Med. 2022. https:\/\/doi.org\/10.5664\/jcsm.10094.","journal-title":"J Clin Sleep Med"},{"issue":"11","key":"1108_CR23","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/jamapediatrics.2020.2539","volume":"174","author":"PD Quinn","year":"2020","unstructured":"Quinn PD, Fine KL, Rickert ME, Sujan AC, Boersma K, Chang Z, et al. Association of opioid prescription initiation during adolescence and young adulthood with subsequent substance-related morbidity. JAMA Pediatr. 2020;174(11):1048. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.2539.","journal-title":"JAMA Pediatr"},{"key":"1108_CR24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-049750","author":"KL Fine","year":"2022","unstructured":"Fine KL, Rickert ME, O\u2019Reilly LM, Sujan AC, Boersma K, Chang Z, et al. Initiation of opioid prescription and risk of suicidal behavior among youth and young adults. Pediatrics. 2022. https:\/\/doi.org\/10.1542\/peds.2020-049750.","journal-title":"Pediatrics"},{"issue":"11","key":"1108_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","volume":"24","author":"JF Ludvigsson","year":"2009","unstructured":"Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659\u201367.","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"1108_CR26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1108_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","volume":"131","author":"A Vezzani","year":"2016","unstructured":"Vezzani A, Fujinami RS, White HS, Preux P-M, Bl\u00fcmcke I, Sander JW, et al. Infections, inflammation and epilepsy. Acta Neuropathol. 2016;131:211\u201334. https:\/\/doi.org\/10.1007\/s00401-015-1481-5.","journal-title":"Acta Neuropathol"},{"key":"1108_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/1745691610383511","author":"M McGue","year":"2010","unstructured":"McGue M, Osler M, Christensen K. Causal inference and observational research: the utility of twins. Perspect Psychol Sci. 2010. https:\/\/doi.org\/10.1177\/1745691610383511.","journal-title":"Perspect Psychol Sci"},{"key":"1108_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-59745-423-0_10","volume":"675","author":"A Ekbom","year":"2011","unstructured":"Ekbom A. The Swedish multi-generation register. Methods Mol Biol. 2011;675:215\u201320.","journal-title":"Methods Mol Biol"},{"key":"1108_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5407","author":"R Sendor","year":"2022","unstructured":"Sendor R, St\u00fcrmer T. Core concepts in pharmacoepidemiology: confounding by indication and the role of active comparators. Pharmacoepidemiol Drug. 2022. https:\/\/doi.org\/10.1002\/pds.5407.","journal-title":"Pharmacoepidemiol Drug"},{"key":"1108_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2941","author":"E Patorno","year":"2017","unstructured":"Patorno E, Glynn RJ, Levin R, Lee MP, Huybrechts KF. Benzodiazepines and risk of all cause mortality in adults: cohort study. BMJ. 2017. https:\/\/doi.org\/10.1136\/bmj.j2941.","journal-title":"BMJ"},{"issue":"2","key":"1108_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jamda.2019.08.017","volume":"21","author":"Y-H Baek","year":"2020","unstructured":"Baek Y-H, Lee H, Kim WJ, Chung J-E, Pratt N, Kalisch Ellett L, et al. Uncertain association between benzodiazepine use and the risk of dementia: a cohort study. J Am Med Directors Assoc. 2020;21(2):201-211.e2.","journal-title":"J Am Med Directors Assoc"},{"issue":"28","key":"1108_CR33","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661\u201379.","journal-title":"Stat Med"},{"issue":"3","key":"1108_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.amjopharm.2007.10.001","volume":"5","author":"MW Bowie","year":"2007","unstructured":"Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother. 2007;5(3):263\u2013303.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"7","key":"1108_CR35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2174\/138920011796504473","volume":"12","author":"G Trifiro","year":"2011","unstructured":"Trifiro G, Spina E. Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems. CDM. 2011;12(7):611\u201320.","journal-title":"CDM"},{"issue":"2","key":"1108_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1524-4733.2009.00671.x","volume":"13","author":"S Xu","year":"2010","unstructured":"Xu S, Ross C, Raebel MA, Shetterly S, Blanchette C, Smith D. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health. 2010;13(2):273\u20137.","journal-title":"Value Health"},{"key":"1108_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7382.219","author":"DG Altman","year":"2003","unstructured":"Altman DG. Statistics notes: interaction revisited: the difference between two estimates. BMJ. 2003. https:\/\/doi.org\/10.1136\/bmj.326.7382.219.","journal-title":"BMJ"},{"issue":"2","key":"1108_CR38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/pds.4123","volume":"26","author":"A Benard-Laribiere","year":"2017","unstructured":"Benard-Laribiere A, Noize P, Pambrun E, Bazin F, Verdoux H, Tournier M, et al. Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study. Pharmacoepidemiol Drug Saf. 2017;26(2):162\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1108_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.chest.2017.07.030","volume":"153","author":"T-Y Chen","year":"2018","unstructured":"Chen T-Y, Winkelman JW, Mao W-C, Liu C-L, Hsu C-Y, Wu C-S. The use of benzodiazepine receptor agonists and the risk of hospitalization for pneumonia: a nationwide population-based nested case-control study. Chest. 2018;153(1):161\u201371.","journal-title":"Chest"},{"issue":"11","key":"1108_CR40","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/pds.4028","volume":"25","author":"G Nakafero","year":"2016","unstructured":"Nakafero G, Sanders RD, Nguyen-Van-Tam JS, Myles PR. The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: a survival analysis using UK Primary Care data. Pharmacoepidemiol Drug Saf. 2016;25(11):1263\u201373. https:\/\/doi.org\/10.1002\/pds.4028.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1108_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/349176","volume":"2015","author":"HP Huemer","year":"2015","unstructured":"Huemer HP. Possible immunosuppressive effects of drug exposure and environmental and nutritional effects on infection and vaccination. Mediators Inflamm. 2015;2015:1\u20137.","journal-title":"Mediators Inflamm"},{"key":"1108_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251632","author":"EL Sparrow","year":"2021","unstructured":"Sparrow EL, James S, Hussain K, Beers SA, Cragg MS, Bogdanov YD. Activation of GABA(A) receptors inhibits T cell proliferation. PLoS ONE. 2021. https:\/\/doi.org\/10.1371\/journal.pone.0251632.","journal-title":"PLoS ONE"},{"issue":"4","key":"1108_CR43","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.103033","volume":"10","author":"A Jafarzadeh","year":"2020","unstructured":"Jafarzadeh A, Hadavi M, Hassanshahi G, Rezaeian M, Vazirinejad R. General anesthetics on immune system cytokines: a narrative review article. Anesth Pain Med. 2020;10(4): e103033.","journal-title":"Anesth Pain Med"},{"key":"1108_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0601-4","author":"Y Fujiwara","year":"2012","unstructured":"Fujiwara Y, Arakawa T, Fass R. Gastroesophageal reflux disease and sleep disturbances. J Gastroenterol. 2012. https:\/\/doi.org\/10.1007\/s00535-012-0601-4.","journal-title":"J Gastroenterol"},{"key":"1108_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13153","author":"I Jullian-Desayes","year":"2017","unstructured":"Jullian-Desayes I, et al. Impact of concomitant medications on obstructive sleep apnoea. Br J Clin Pharmacol. 2017. https:\/\/doi.org\/10.1111\/bcp.13153.","journal-title":"Br J Clin Pharmacol"},{"key":"1108_CR46","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8744","author":"EM Mok","year":"2020","unstructured":"Mok EM, Greenough G, Pollack CC. Untreated obstructive sleep apnea is associated with increased hospitalization from influenza infection. J Clin Sleep Med. 2020. https:\/\/doi.org\/10.5664\/jcsm.8744.","journal-title":"J Clin Sleep Med"},{"key":"1108_CR47","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s11882-013-0340-5","volume":"13","author":"E-J Katle","year":"2013","unstructured":"Katle E-J, Hatlebakk JG, Steinsv\u00e5g S. Gastroesophageal reflux and rhinosinusitis. Curr Allergy Asthma Rep. 2013;13:228\u2013223. https:\/\/doi.org\/10.1007\/s11882-013-0340-5.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1108_CR48","doi-asserted-by":"publisher","DOI":"10.3109\/08923979309026001","author":"E Jirillo","year":"1993","unstructured":"Jirillo E, Maffione AB, Cannuscio B, Calvello R, Greco B, Covelli V. Triazolobenzodiazepines exert immunopotentiating activities on normal human peripheral blood lymphocytes. Immunopharmacol Immunotoxicol. 1993. https:\/\/doi.org\/10.3109\/08923979309026001.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"2","key":"1108_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/08923979809038539","volume":"20","author":"V Covelli","year":"1998","unstructured":"Covelli V, Maffione AB, Nacci C, Tat\u00f2 E, Jirillo E. Stress, Neuropsychiatric disorders and immunological effects exerted by benzodiazepines. Immunopharmacol Immunotoxicol. 1998;20(2):199\u2013209. https:\/\/doi.org\/10.3109\/08923979809038539.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1108_CR50","unstructured":"The Swedish National Board of Health and Welfare. National guidelines for care and support in cases of addiction and dependence. Support for control and management [Nationella riktlinjer f\u00f6r v\u00e5rd och st\u00f6d vid missbruk och beroende. St\u00f6d f\u00f6r styrning och ledning]. Available from www.socialstyrelsen.se. 2019; Accessed 15 October 2022."},{"key":"1108_CR51","unstructured":"National Institute for Health and Care Excellance (NICE). Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia. 2004. Available from https:\/\/www.nice.org.uk\/guidance\/ta77. Accessed 15 January 2023."},{"key":"1108_CR52","unstructured":"National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management. Clinical guideline (CG113) [Published: 26 January 2011 Last updated: 15 June 2020]. https:\/\/www.nice.org.uk\/guidance\/cg113. 2020; Accessed 15 January 2023."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01108-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-024-01108-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01108-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T07:21:51Z","timestamp":1725520911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-024-01108-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1108"],"URL":"https:\/\/doi.org\/10.1007\/s40263-024-01108-w","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"11 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was supported by grants from the Swedish Research Council (grant No 2019-01408, AS), Region Stockholm (ALF Medicine; grant nos. 20190379 and RS2020-0731, AS), Karolinska Institutet (KID funding; grant no. 2021-00505, AS, and research funding; grant no. FS-2022:0010, AS). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, or approval of the manuscript; and decision to submit the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Prof Mataix-Cols receives royalties for contributing articles to UpToDate, Inc, and is part owner of Scandinavian E-Health AB, all outside the submitted work. The other authors have no conflicts of interest to declare in relation to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The study was approved by the Swedish Ethical Review Authority (reference number 2020-06540).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The requirement for informed consent was waived because the study is register-based, and all individual data were de-identified.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Sharing individual-level data are restricted by Swedish data protection laws, therefore the data underlying our findings cannot be made publicly accessible. The data for this study were made available to the authors by ethical approval and were sourced from several registers held by the Swedish governmental agencies. For data access inquiries, the researchers may apply through the Swedish Ethical Review Authority (\n                      \n                      ) and the primary data owners as the National Board of Health and Welfare (\n                      \n                      ) and Statistics Sweden (\n                      \n                      ), in accordance with Swedish law.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"The code used for analyses are available from the corresponding author upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Conceptualization and methodology: AS, DMC, XW, and KI. Formal analysis: XW. Interpretation of data and critical revision of the manuscript for important intellectual content: all authors. Original draft preparation: AS and XW. Funding acquisition: AS. Supervision: AS, DMC, ZC, and NJ-L. Final manuscript approval: all authors. All authors have read and approved the final submitted manuscript, and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors Contributions"}}]}}